1	Planned administration/ administration of a vaccine not foreseen by the study protocol within 30 days prior to until 42 days after the study vaccine dose with the exception of inactivated vaccines such as pneumococcal Haemophilus influenzae type b conjugate vaccines inactivated influenza hepatitis A|vaccine[141,148]|||||||30 days[94,101]|||11094|11094|vaccine
1	Planned administration/ administration of a vaccine not foreseen by the study protocol within 30 days prior to until 42 days after the study vaccine dose with the exception of inactivated vaccines such as pneumococcal Haemophilus influenzae type b conjugate vaccines inactivated influenza hepatitis A|vaccine[94,101]||||||||||11094|11094|vaccine
1	Planned administration/ administration of a vaccine not foreseen by the study protocol within 30 days prior to until 42 days after the study vaccine dose with the exception of inactivated vaccines such as pneumococcal Haemophilus influenzae type b conjugate vaccines inactivated influenza hepatitis A|inactivated vaccines[176,196]||||||||||1242420|1242420|inactivated vaccines
1	Planned administration/ administration of a vaccine not foreseen by the study protocol within 30 days prior to until 42 days after the study vaccine dose with the exception of inactivated vaccines such as pneumococcal Haemophilus influenzae type b conjugate vaccines inactivated influenza hepatitis A|pneumococcal[205,217]|||||||||C0358314|106467|106467|pneumococcal vaccine
1	Planned administration/ administration of a vaccine not foreseen by the study protocol within 30 days prior to until 42 days after the study vaccine dose with the exception of inactivated vaccines such as pneumococcal Haemophilus influenzae type b conjugate vaccines inactivated influenza hepatitis A|Haemophilus influenzae type b[218,247]|||||||||C0121772|50937|50937|haemophilus b
1	Planned administration/ administration of a vaccine not foreseen by the study protocol within 30 days prior to until 42 days after the study vaccine dose with the exception of inactivated vaccines such as pneumococcal Haemophilus influenzae type b conjugate vaccines inactivated influenza hepatitis A|conjugate vaccines[248,266]||||||||||90039|90039|conjugate vaccines
2	or B vaccine or diphtheria/tetanus-containing vaccines which can be administered up to eight days before the study vaccine dose|vaccine[306,313]||||||||||11094|11094|vaccine
2	or B vaccine or diphtheria/tetanus-containing vaccines which can be administered up to eight days before the study vaccine dose|vaccine[416,423]|||||||eight days[388,398]|||11094|11094|vaccine
2	or B vaccine or diphtheria/tetanus-containing vaccines which can be administered up to eight days before the study vaccine dose|vaccines[347,355]|||||||||C0042210|11094|11094|vaccines
